Head-to-head · Cost-Efficiency Index
YourEra vs Citizen Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
YourEra
Shoppers chasing the lowest sticker price who will verify what's actually billed after the first month.
Visit YourEraCitizen Meds
Shoppers who want to buy a low-dose starting month without any subscription commitment.
Visit Citizen MedsThe verdict
Citizen Meds takes it, leading the Cost-Efficiency Index 64 to 62. Citizen Meds is a compounded-GLP-1 telehealth seller using a one-time-purchase, no-subscription model built around a mandatory dose-titration schedule: each month's vial is bought separately and its price rises with the dose. YourEra still earns a C — Shoppers chasing the lowest sticker price who will verify what's actually billed after the first month.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Citizen Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | YourEra | Citizen Meds |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 64/100 |
| Semaglutide / mo | $179/mo (all doses, month-to-month, compounded) | $125/mo (0.25 mg dose, compounded) |
| Tirzepatide / mo | $259/mo (all doses, month-to-month, compounded) | $145/mo (2.5 mg dose, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $1,500 |
| Tirzepatide / yr (modeled) | $3,108 | $1,740 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #171 | #176 |
YourEra
62/100Where the value is
- A 6-month prepay drops semaglutide to $99/month, among the lowest compounded-GLP-1 headline prices we track
- No membership-fee structure; the site markets "no hidden fees" and "Same price at every dose"
- Prescriptions are "issued only if deemed medically appropriate" after evaluation by licensed US clinicians, stated plainly
The tradeoffs
- The advertised $99/month requires a 6-month prepay — paying month to month costs $149 for the first month and $179/month after, nearly double the headline
- Tirzepatide's advertised $179 is a first-month intro, not a prepay rung: the page's own words are "Month-to-month intro. Then $259/mo." — so the two molecules' headline discounts work in two different ways on one page
Citizen Meds
64/100Where the value is
- No subscription — every month is a separate one-time purchase, so there's no auto-renewing commitment to cancel
- LegitScript badge genuinely renders on the live homepage (seal 11945825), correcting the prior claim of no certification
- PCCA compounding-pharmacy trade-association badge and PCAB-labeled imagery displayed
The tradeoffs
- The headline '$125'/'$145' price is Month-1-only at the lowest dose; the mandatory titration schedule pushes maintenance-dose months to $395-$545, roughly 3-4x the advertised figure
- No compounding pharmacy is named anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.